IL327445A - חיסון נגיף קורונה עם סוכר נמוך ושיטות שלו - Google Patents
חיסון נגיף קורונה עם סוכר נמוך ושיטות שלוInfo
- Publication number
- IL327445A IL327445A IL327445A IL32744526A IL327445A IL 327445 A IL327445 A IL 327445A IL 327445 A IL327445 A IL 327445A IL 32744526 A IL32744526 A IL 32744526A IL 327445 A IL327445 A IL 327445A
- Authority
- IL
- Israel
- Prior art keywords
- sugar
- methods
- low
- coronavirus vaccine
- coronavirus
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5123—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
- A61K2039/645—Dendrimers; Multiple antigen peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363588932P | 2023-10-09 | 2023-10-09 | |
| US202463549343P | 2024-02-02 | 2024-02-02 | |
| US202463575093P | 2024-04-05 | 2024-04-05 | |
| PCT/US2024/023597 WO2024215616A2 (en) | 2023-04-08 | 2024-04-08 | Methods and compositions for dendritic cell targeting vaccines |
| PCT/US2024/050353 WO2025080565A1 (en) | 2023-10-09 | 2024-10-08 | Low-sugar coronavirus vaccine and methods thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL327445A true IL327445A (he) | 2026-05-01 |
Family
ID=95396272
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL327445A IL327445A (he) | 2023-10-09 | 2024-10-08 | חיסון נגיף קורונה עם סוכר נמוך ושיטות שלו |
Country Status (4)
| Country | Link |
|---|---|
| AU (1) | AU2024359608A1 (he) |
| IL (1) | IL327445A (he) |
| TW (1) | TW202517670A (he) |
| WO (1) | WO2025080565A1 (he) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120923537A (zh) * | 2025-07-30 | 2025-11-11 | 天津大学 | 一种铁死亡抑制型类磷脂材料及其应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230016193A (ko) * | 2020-05-20 | 2023-02-01 | 알렉산드루 아드리안 헨리히 | 베타코로나바이러스에 대한 면역화를 위한 바이러스 백신 벡터 |
-
2024
- 2024-10-08 IL IL327445A patent/IL327445A/he unknown
- 2024-10-08 TW TW113138305A patent/TW202517670A/zh unknown
- 2024-10-08 WO PCT/US2024/050353 patent/WO2025080565A1/en active Pending
- 2024-10-08 AU AU2024359608A patent/AU2024359608A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| TW202517670A (zh) | 2025-05-01 |
| WO2025080565A1 (en) | 2025-04-17 |
| AU2024359608A1 (en) | 2026-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4135847A4 (en) | Coronavirus vaccine | |
| EP4117725A4 (en) | CORONAVIRUS VACCINE METHODS AND COMPOSITIONS | |
| EP4114460A4 (en) | Vaccines against sars-cov-2 and other coronaviruses | |
| GB2594365B (en) | Coronavirus vaccine | |
| IL284640A (he) | מעכבי pcsk9 ושיטות לשימוש בהם | |
| ZA202210641B (en) | Coronavirus vaccine | |
| EP4164687A4 (en) | IMPROVED CORONAVIRUS VACCINE | |
| IL284661A (he) | מעכבי pcsk9 ושיטות לשימוש בהם | |
| EP4313143A4 (en) | Coronavirus vaccine formulations | |
| EP4240436A4 (en) | SCAFFOLDING AND TISSUE CONSTRUCTIONS | |
| GB202217951D0 (en) | Coronavirus vaccine | |
| IL288310A (he) | מודולטורים של cot ושיטות לשימוש בהם | |
| IL297070A (he) | חיסון נגד נגיף הקורונה | |
| EP4376883A4 (en) | RNA VACCINES | |
| EP4440613A4 (en) | CORONAVIRUS VACCINE FORMULATIONS | |
| IL311855A (he) | תכשירי lnp אימונוגניים ושיטותיהם | |
| IL304401A (he) | איגור תאים דמוי-בלאסטוציסט ושיטות | |
| EP4159234A4 (en) | VACCINE AGAINST SARS-COV-2 | |
| GB2620028B8 (en) | Coronavirus vaccine | |
| EP4228546C0 (en) | SPLIT DENTURE | |
| EP4230741A4 (en) | Beta coronavirus cold acclimatized strain and vaccine | |
| IL286492A (he) | סוכריד עמיד בפני סיאלידה ואופן ייצור ושימוש אותו | |
| EP4159853A4 (en) | GENOME EDITING SYSTEM AND METHOD | |
| IL285611A (he) | מערכת חיסון קרקע מבוססת מיקרו-אצות ושיטות לשימוש | |
| EP4031169A4 (en) | Bee vaccines and methods of use |